Schedule | Baseline | Treatment phase | Follow-up phase | |||
---|---|---|---|---|---|---|
0 months | 2 months | 4 months | 6 months | 1 year | 1.5 years | |
Patients | ||||||
Informed consent | × | |||||
Medical history | × | |||||
Physical examination | × | |||||
Randomization | × | |||||
Intervention | ||||||
ta-VNS group | Transcutaneous stimulation at the auricular concha | |||||
tan-VNS group | Transcutaneous stimulation at marginal area of the auricle | |||||
Comparison | ||||||
Control group | No transcutaneous stimulation is provided | |||||
Outcomes | ||||||
Seizure frequency | × | × | × | × | × | × |
EEG | × | × | ||||
HRV | × | × | ||||
QOL | × | × | ||||
Safety | ||||||
Adverse events | × | × | × | × | × | × |